StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.17−0.18 (-13.33%)

Close on Nov 16, 2026Market cap $61.40MP/E –Yield –

OKYO Pharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for OKYO Pharma

OKYO Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More OKYO Pharma figures

See a number that looks wrong?